Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – Expert decision and opinion in the context of the Clinical Evaluation Consultation...

This scientific opinion reflects the views of independent experts (MDR Article 106) on the clinical evaluation assessment report (CEAR) of the notified body. The...

USA – FDA updates guidance on identifying and responding to deficiencies

The US Food and Drug Administration has revised the guidance document Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions to update the...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – 37 ème organisme notifié au titre du Règlement 2017/745

37 ème organisme notifié au titre du Règlement 2017/745

USA – FDA draft guidance covers low-level light therapy devices

The US Food and Drug Administration (FDA) has published a draft guidance for low-level light therapy (LLLT) devices, or photobiomodulation (PBM) devices, which are...

USA – Legacy devices report highlights need for data to support future policies

More data is needed to understand the risks legacy connected medical devices pose to the healthcare system, particularly in their vulnerability to cyberattack. That...

Australia – New guidance published on manufacturer evidence for IVD medical devices

We no longer accept ISO 13485 certificates to support applications for new In Vitro Diagnostic (IVD) medical devices, except if the manufacturer made a...

International – Requirements for Regulatory Authority Recognition of Conformity Assessment Bodies Conducting Medical Device...

Standards perform a key role in the conformity assessment process; however, utilizing existing standards for recognition of medical device CABs performing regulatory reviews presents challenges. Regulatory...
ANSM : Antibiotiques et Résistance Bactérienne : Une Menace Mondiale, des Conséquences Individuelles

France – Déclarer l’indisponibilité d’un dispositif médical : la procédure évolue

A partir du 1er septembre 2024, la procédure pour anticiper et gérer l’indisponibilité de dispositifs médicaux (DM) et dispositifs médicaux in vitro (DMDIV) évolue, dans la continuité...
ANSM – Comité d’interface du 6 Février – EUDAMED

France – L’ANSM demande aux fabricants de dispositifs médicaux qui envoient un avis de...

Des concertations menées par l’ANSM avec des pharmaciens qui distribuent ou utilisent des dispositifs médicaux ou dispositifs médicaux de diagnostic in vitro, montrent que la...

International – Medical Device Regulatory Review Report: Guidance Regarding Information to be Included

The scope of this guidance document is limited to the information participating IMDRF Regulatory Authorities require in medical device regulatory review reports, the format of reports,...

NOS PROCHAINES FORMATIONS